{
    "title": "Severe sarcopenia (loss of muscle) 6 X more likely in women with rheumatoid arthritis having low vitamin D",
    "slug": "severe-sarcopenia-loss-of-muscle-6-x-more-likely-in-women-with-rheumatoid-arthri-g-low-vitamin-d",
    "aliases": [
        "/Severe+sarcopenia+loss+of+muscle+6+X+more+likely+in+women+with+rheumatoid+arthritis+having+low+vitamin+D+\u2013+Oct+2021",
        "/12994"
    ],
    "tiki_page_id": 12994,
    "date": "2021-10-16",
    "categories": [
        "Rheumatoid Arthritis"
    ],
    "tags": [
        "Rheumatoid Arthritis",
        "autoimmune",
        "bone",
        "bone mineral density",
        "depression",
        "diabetes",
        "diabetes and vitamin d receptor",
        "falls fractures",
        "genetics",
        "high dose",
        "hypertension",
        "intervention",
        "life span",
        "metabolic",
        "mood disorders",
        "mortality",
        "pain",
        "rheumatoid arthritis",
        "therapeutic intervention",
        "vitamin d",
        "vitamin d receptor"
    ]
}


#### References

1. Chen, L. K. et al. Sarcopenia in Asia: consensus report of the asian working group for aarcopenia. J. Am. Med. Dir. Assoc. 15, 95–101. https://doi.org/10.1016/j.jamda.2013.11.025 (2014). - DOI - PubMed

1. Beaudart, C., Zaaria, M., Pasleau, F., Reginster, J. Y. & Bruyere, O. Health outcomes of sarcopenia: a systematic review and meta-analysis. PLoS ONE 12, e0169548. https://doi.org/10.1371/journal.pone.0169548 (2017). - DOI - PubMed - PMC

1. Yeung, S. S. Y. et al. Sarcopenia and its association with falls and fractures in older adults: a systematic review and meta-analysis. J. Cachexia Sarcopenia Muscle 10, 485–500. https://doi.org/10.1002/jcsm.12411 (2019). - DOI - PubMed - PMC

1. Bowen, T. S., Schuler, G. & Adams, V. Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training. J. Cachexia Sarcopenia Muscle 6, 197–207. https://doi.org/10.1002/jcsm.12043 (2015). - DOI - PubMed - PMC

1. Yoshimura, Y. et al. Interventions for treating sarcopenia: a systematic review and meta-analysis of randomized controlled studies. J. Am. Med. Dir. Assoc. 18, 553 e551. https://doi.org/10.1016/j.jamda.2017.03.019 (2017). - DOI

1. Petermann-Rocha, F. et al. Factors associated with sarcopenia: a cross-sectional analysis using UK Biobank. Maturitas 133, 60–67. https://doi.org/10.1016/j.maturitas.2020.01.004 (2020). - DOI - PubMed

1. Sokka, T., Hakkinen, A., Krishnan, E. & Hannonen, P. Similar prediction of mortality by the health assessment questionnaire in patients with rheumatoid arthritis and the general population. Ann. Rheum. Dis. 63, 494–497. https://doi.org/10.1136/ard.2003.009530 (2004). - DOI - PubMed - PMC

1. Cramer, J. T. et al. Impacts of high-protein oral nutritional supplements among malnourished men and women with sarcopenia: a multicenter, randomized, double-blinded, controlled trial. J. Am. Med. Dir. Assoc. 17, 1044–1055. https://doi.org/10.1016/j.jamda.2016.08.009 (2016). - DOI - PubMed

1. Cruz-Jentoft, A. J. & Sayer, A. A. Sarcopenia. The Lancet 393, 2636–2646. https://doi.org/10.1016/s0140-6736(19)31138-9 (2019). - DOI

1. Torii, M. et al. Prevalence and factors associated with sarcopenia in patients with rheumatoid arthritis. Mod. Rheumatol. 29, 589–595. https://doi.org/10.1080/14397595.2018.1510565 (2019). - DOI - PubMed

1. Wu, C. H. et al. Prevalence and associated factors of sarcopenia and severe sarcopenia in older Taiwanese living in rural community: the Tianliao Old People study 04. Geriatr. Gerontol. Int. 14(Suppl 1), 69–75. https://doi.org/10.1111/ggi.12233 (2014). - DOI - PubMed

1. Giles, J. T. et al. Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapies. Arthritis Rheum. 59, 807–815. https://doi.org/10.1002/art.23719 (2008). - DOI - PubMed - PMC

1. Dzik, K. P. & Kaczor, J. J. Mechanisms of  **vitamin D**  on skeletal muscle function: oxidative stress, energy metabolism and anabolic state. Eur. J. Appl. Physiol. 119, 825–839. https://doi.org/10.1007/s00421-019-04104-x (2019). - DOI - PubMed - PMC

1. Wang, J. et al.  **vitamin D**  is related to handgrip strength in adult men aged 50 years and over: a population study from the TCLSIH cohort study. Clin. Endocrinol. (Oxf) 90, 753–765. https://doi.org/10.1111/cen.13952 (2019). - DOI

1. Wicherts, I. S. et al.  **vitamin D**  status predicts physical performance and its decline in older persons. J. Clin. Endocrinol. Metab. 92, 2058–2065. https://doi.org/10.1210/jc.2006-1525 (2007). - DOI - PubMed

1. Beaudart, C. et al. The effects of  **vitamin D**  on skeletal muscle strength, muscle mass, and muscle power: a systematic review and meta-analysis of randomized controlled trials. J. Clin. Endocrinol. Metab. 99, 4336–4345. https://doi.org/10.1210/jc.2014-1742 (2014). - DOI - PubMed

1. Gkekas, N. K. et al. The effect of  **vitamin D**  plus protein supplementation on sarcopenia: a systematic review and meta-analysis of randomized controlled trials. Maturitas 145, 56–63. https://doi.org/10.1016/j.maturitas.2021.01.002 (2021). - DOI - PubMed

1. Furuya, T. et al. Prevalence of and factors associated with  **vitamin D**  deficiency in 4,793 Japanese patients with rheumatoid arthritis. Clin. Rheumatol. 32, 1081–1087. https://doi.org/10.1007/s10067-013-2216-4 (2013). - DOI - PubMed

1. Hashimoto, M. et al. Increase of hemoglobin levels by anti-IL-6 receptor antibody (tocilizumab) in rheumatoid arthritis. PLoS ONE 9, e98202. https://doi.org/10.1371/journal.pone.0098202 (2014). - DOI - PubMed - PMC

1. Minamino, H. et al. Urinary sodium-to-potassium ratio associates with hypertension and current disease activity in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Res. Ther. 23, 96. https://doi.org/10.1186/s13075-021-02479-x (2021). - DOI - PubMed - PMC

1. Singh, J. A. et al. 2015 American college of rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care Res.. (Hoboken) 68, 1–25. https://doi.org/10.1002/acr.22783 (2016). - DOI

1. Minamino, H. et al. Habitual fish intake negatively correlates with prevalence of frailty among patients with rheumatoid arthritis. Sci. Rep. 11, 5104. https://doi.org/10.1038/s41598-021-84479-0 (2021). - DOI - PubMed - PMC

1. Chen, L. K. et al. Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J. Am. Med. Dir. Assoc. 21, 300–307. https://doi.org/10.1016/j.jamda.2019.12.012 (2020). - DOI - PubMed

1. Rubenstein, L. Z., Harker, J. O., Salva, A., Guigoz, Y. & Vellas, B. Screening for undernutrition in geriatric practice: developing the short-form mini-nutritional assessment (MNA-SF). J. Gerontol. A Biol. Sci. Med. Sci. 56, M366-372. https://doi.org/10.1093/gerona/56.6.m366 (2001). - DOI - PubMed

1. Pearce, S. H. & Cheetham, T. D. Diagnosis and management of  **vitamin D**  deficiency. BMJ 340, b5664. https://doi.org/10.1136/bmj.b5664 (2010). - DOI - PubMed

1. Yamada, Y. et al. Glucocorticoid use is an independent risk factor for developing sarcopenia in patients with rheumatoid arthritis: from the CHIKARA study. Clin. Rheumatol. 39, 1757–1764. https://doi.org/10.1007/s10067-020-04929-4 (2020). - DOI - PubMed

1. Bonnet, N., Bourgoin, L., Biver, E., Douni, E. & Ferrari, S. RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass. J. Clin. Invest. 129, 3214–3223. https://doi.org/10.1172/JCI125915 (2019). - DOI - PubMed - PMC

1. Marozik, P., Rudenka, A., Kobets, K. & Rudenka, E.  **vitamin D**  status, bone mineral density, and VDR gene polymorphism in a cohort of Belarusian postmenopausal women. Nutrients https://doi.org/10.3390/nu13030837 (2021). - DOI - PubMed - PMC

1. Okereke, O. I. et al. Effect of long-term  **vitamin D** 3 supplementation vs placebo on risk of depression or clinically relevant depressive symptoms and on change in mood scores: a randomized clinical trial. JAMA 324, 471–480. https://doi.org/10.1001/jama.2020.10224 (2020). - DOI - PubMed - PMC

1. Haque, U. J. & Bartlett, S. J. Relationships among  **vitamin D** , disease activity, pain and disability in rheumatoid arthritis. Clin. Exp. Rheumatol. 28, 745–747 (2010). - PubMed

1. Rossini, M. et al.  **vitamin D**  deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability. Arthritis Res. Ther. 12, R216. https://doi.org/10.1186/ar3195 (2010). - DOI - PubMed - PMC

1. Toffanello, E. D. et al.  **vitamin D**  and physical performance in elderly subjects: the Pro.V.A study. PLoS One 7, e34950. https://doi.org/10.1371/journal.pone.0034950 (2012). - DOI - PubMed - PMC

1. Vaes, A. M. M. et al. The association between 25-hydroxy **vitamin D**  concentration, physical performance and frailty status in older adults. Eur. J. Nutr. 58, 1173–1181. https://doi.org/10.1007/s00394-018-1634-0 (2019). - DOI - PubMed

1. Jain, S. K., Parsanathan, R., Achari, A. E., Kanikarla-Marie, P. & Bocchini, J. A. Jr. Glutathione stimulates  **vitamin D**  regulatory and glucose-metabolism genes, lowers oxidative stress and inflammation, and increases 25-hydroxy- **vitamin D**  levels in blood: a novel approach to treat 25-hydroxy **vitamin D**  deficiency. Antioxid Redox Signal 29, 1792–1807. https://doi.org/10.1089/ars.2017.7462 (2018). - DOI - PubMed - PMC

1. Bischoff-Ferrari, H. A. et al.  **vitamin D**  receptor expression in human muscle tissue decreases with age. J. Bone Miner. Res. 19, 265–269. https://doi.org/10.1359/jbmr.2004.19.2.265 (2004). - DOI - PubMed

1. Ryan, Z. C. et al. 1alpha,25-dihydroxy **vitamin D** 3 regulates mitochondrial oxygen consumption and dynamics in human skeletal muscle cells. J. Biol. Chem. 291, 1514–1528. https://doi.org/10.1074/jbc.M115.684399 (2016). - DOI - PubMed

1. Sinha, A., Hollingsworth, K. G., Ball, S. & Cheetham, T. Improving the  **vitamin D**  status of  **vitamin D**  deficient adults is associated with improved mitochondrial oxidative function in skeletal muscle. J. Clin. Endocrinol. Metab. 98, E509-513. https://doi.org/10.1210/jc.2012-3592 (2013). - DOI - PubMed

1. Charoenngam, N. & Holick, M. F. Immunologic effects of  **vitamin D**  on human health and disease. Nutrients https://doi.org/10.3390/nu12072097 (2020). - DOI - PubMed - PMC

1. Tang, J. et al. Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response. J. Immunol. 182, 4624–4632. https://doi.org/10.4049/jimmunol.0801543 (2009). - DOI - PubMed

1. Villaggio, B., Soldano, S. & Cutolo, M. 1,25-dihydroxy **vitamin D** 3 downregulates aromatase expression and inflammatory cytokines in human macrophages. Clin. Exp. Rheumatol. 30, 934–938 (2012). - PubMed

1. Boonstra, A. et al. 1alpha,25-dihydroxy **vitamin D** 3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J. Immunol. 167, 4974–4980. https://doi.org/10.4049/jimmunol.167.9.4974 (2001). - DOI - PubMed

1. Gregori, S., Giarratana, N., Smiroldo, S., Uskokovic, M. & Adorini, L. A 1alpha,25-dihydroxy **vitamin D** (3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 51, 1367–1374. https://doi.org/10.2337/diabetes.51.5.1367 (2002). - DOI - PubMed

1. McInnes, I. B. & Schett, G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat. Rev. Immunol. 7, 429–442. https://doi.org/10.1038/nri2094 (2007). - DOI - PubMed

1. Mouterde, G. et al. Association between  **vitamin D**  deficiency and disease activity, disability, and radiographic progression in early rheumatoid arthritis: The ESPOIR cohort. J. Rheumatol. 47, 1624–1628. https://doi.org/10.3899/jrheum.190795 (2020). - DOI - PubMed